|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/26/13 Oragenics Inc 10-K 12/31/12 74:5.9M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 863K
2: EX-10.26 Form of Employee Stock Option Agreement HTML 42K
3: EX-10.27 Form of Consultant Stock Option Agreement HTML 39K
4: EX-23.1 Consent of Experts or Counsel HTML 20K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 25K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 25K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 20K
8: EX-32.2 Certification -- §906 - SOA'02 HTML 20K
52: R1 Document and Entity Information HTML 48K
42: R2 Balance Sheets HTML 92K
50: R3 Balance Sheets (Parenthetical) HTML 44K
54: R4 Statements of Operations HTML 78K
69: R5 Statements of Changes in Shareholders' Equity HTML 83K
(Deficit)
44: R6 Statements of Cash Flows HTML 140K
49: R7 Statements of Cash Flows (Parenthetical) HTML 19K
38: R8 Basis of Presentation HTML 29K
29: R9 Significant Accounting Policies HTML 46K
70: R10 Inventory, net HTML 32K
56: R11 Property and Equipment, net HTML 34K
55: R12 Related Party Transactions HTML 29K
60: R13 Accounts Payable and Accrued Expenses HTML 34K
61: R14 Short Term Notes Payable HTML 30K
59: R15 Convertible Revolving Notes Payable to Shareholder HTML 38K
62: R16 Shareholders' Equity HTML 65K
51: R17 Stock Compensation Plan HTML 58K
53: R18 Licenses HTML 30K
58: R19 Retirement Plan HTML 30K
74: R20 Income Taxes HTML 65K
65: R21 Commitments and Contingencies HTML 53K
46: R22 Unaudited Quarterly Financial Information HTML 43K
57: R23 Significant Accounting Policies (Policies) HTML 136K
48: R24 Inventory, net (Tables) HTML 30K
23: R25 Property and Equipment, net (Tables) HTML 32K
66: R26 Accounts Payable and Accrued Expenses (Tables) HTML 33K
71: R27 Short Term Notes Payable (Tables) HTML 29K
33: R28 Shareholders' Equity (Tables) HTML 29K
32: R29 Stock Compensation Plan (Tables) HTML 42K
36: R30 Income Taxes (Tables) HTML 64K
37: R31 Commitments and Contingencies (Tables) HTML 25K
39: R32 Unaudited Quarterly Financial Information (Tables) HTML 39K
21: R33 Basis of Presentation (Details) HTML 46K
63: R34 Significant Accounting Policies (Details) HTML 75K
45: R35 Inventory, net (Details) HTML 42K
47: R36 Property and Equipment, net (Details) HTML 35K
26: R37 Property and Equipment, net (Details Textual) HTML 23K
73: R38 Related Party Transactions (Details) HTML 41K
15: R39 Accounts Payable and Accrued Expenses (Details) HTML 61K
40: R40 Short Term Notes Payable (Details) HTML 25K
68: R41 Short Term Notes Payable (Details Textual) HTML 31K
25: R42 Convertible Revolving Notes Payable to Shareholder HTML 125K
(Details)
31: R43 Shareholders' Equity (Details) HTML 37K
35: R44 Shareholders' Equity (Details Textual) HTML 219K
43: R45 Stock Compensation Plan (Details) HTML 44K
20: R46 Stock Compensation Plan (Details 1) HTML 65K
28: R47 Stock Compensation Plan (Details Textual) HTML 67K
18: R48 Licenses (Details) HTML 44K
67: R49 Retirement Plan (Details) HTML 23K
24: R50 Income Taxes (Details) HTML 38K
64: R51 Income Taxes (Details 1) HTML 72K
27: R52 Income Taxes (Details 2) HTML 44K
41: R53 Income Taxes (Details 3) HTML 32K
16: R54 Income Taxes (Details Textual) HTML 58K
19: R55 Commitments and Contingencies (Details) HTML 35K
34: R56 Commitments and Contingencies (Details Textual) HTML 96K
22: R57 Unaudited Quarterly Financial Information HTML 40K
(Details)
72: XML IDEA XML File -- Filing Summary XML 104K
30: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 718K
9: EX-101.INS XBRL Instance -- orni-20121231 XML 945K
11: EX-101.CAL XBRL Calculations -- orni-20121231_cal XML 180K
12: EX-101.DEF XBRL Definitions -- orni-20121231_def XML 570K
13: EX-101.LAB XBRL Labels -- orni-20121231_lab XML 1.20M
14: EX-101.PRE XBRL Presentations -- orni-20121231_pre XML 858K
10: EX-101.SCH XBRL Schema -- orni-20121231 XSD 187K
17: ZIP XBRL Zipped Folder -- 0001193125-13-126950-xbrl Zip 136K
| Form of Consultant Stock Option Agreement |
Exhibit 10.27
Oragenics, Inc.
Notice of Grant of Stock Options
and Stock Option Award Agreement
Dear [insert name of consultant]
Oragenics, Inc. hereby grants you Stock Options to purchase up to shares of our Common Stock (the “Stock Options”), subject to the terms and conditions set forth in this Notice of Grant, the Terms and Conditions attached hereto as Appendix A and terms of the Oragenics, Inc. 2012 Equity Incentive Plan. The key terms of the Stock Options granted to you are as follows.
Number of Shares: Under these Stock Options, you may purchase up to shares of Common Stock.
Exercise Price: The purchase price for your Stock Options shall be $ per share.
Date of Grant: The “Date of Grant” for your Stock Options is , 2013.
Vesting Schedule: Your Stock Options will be exercisable only after they become “vested.” Vesting is subject to your continued performance of consulting services for Oragenics through the following vesting dates.
| Vesting Date |
Vested Percentage of Shares |
Total Number of Purchasable Shares | ||
Not ISOs: These Stock Options are not “incentive stock options” under the federal tax laws.
Expiration Date: If not previously exercised or forfeited, the Stock Options shall expire on , 2023.
Your signature below acknowledges your agreement that these Stock Options granted to you are subject to all of the terms and conditions contained in Appendix A and the Plan. PLEASE BE SURE TO READ APPENDIX A, WHICH CONTAINS THE SPECIFIC TERMS AND CONDITIONS OF YOUR AWARD.
Please sign one copy of this Stock Option Agreement (the other copy is for your files) and return the signed copy to [me/or insert name or position] no later than [March 31, 2013].
| ORAGENICS, INC. | ||||||
|
|
| |||||
| Date | John Bonfiglio, President & CEO | |||||
| Consultant | ||||||
|
|
| |||||
| Print name: |
|
Date | ||||
APPENDIX A
TERMS AND CONDITIONS OF STOCK OPTIONS
1. Grant. Oragenics, Inc. (the “Company”) has granted the consultant of the Company named in the attached Notice of Grant (the “Consultant”) stock options to purchase the number of shares of the Company’s Common Stock, $.001 par value per share (“Common Stock”), specified in the Notice of Grant attached hereto and incorporated into this Award Agreement by reference. Capitalized terms used and not defined in this Agreement will have the meaning set forth in the Plan.
The Stock Options granted under this Award Agreement are not intended to be Incentive Stock Options covered by Section 422 of the Code.
2. Incorporation of the 2012 Incentive Plan. The Stock Options have been granted pursuant to the provisions of the Company’s 2012 Equity Incentive Plan, and the terms and definitions of the 2012 Equity Incentive Plan are incorporated into this Award Agreement by reference and made a part of this Award Agreement. The Consultant acknowledges receipt of a copy of the 2012 Equity Incentive Plan.
3. Purchase Price. The price per share to be paid by the Consultant for the shares purchased pursuant to these Stock Options (the “Exercise Price”) shall be as specified in the Notice of Grant. This Exercise Price shall be an amount not less than the Fair Market Value of a share of Common Stock as of the Date of Grant (as defined in the Plan and specified in the Notice of Grant).
4. Exercise Terms. The Stock Options shall become vested and exercisable in the amounts and at the time(s) described in vesting schedule set forth in the Notice of Grant. The Stock Options shall become vested and exercisable only if the Consultant continues to regularly perform services for the Company as a consultant through the vesting dates set forth in the vesting schedule in Notice of Grant.
The Consultant must exercise the Stock Options for at least 100 shares, or, if less the full number of shares shown as Purchasable Shares in the vesting schedule in the Notice of Grant as to which the Stock Options remain unexercised.
If the Stock Options are not exercised with respect to all or any part of the shares subject to the Stock Options prior to the expiration date specified in the Notice of Grant (which shall be no later than ten (10) years from the date of grant), the Stock Options shall expire and any shares with respect to which the Stock Options were not exercised shall no longer be Purchasable Shares subject to the Stock Options.
5. Option Non-Transferable. No Stock Options shall be transferable by the Consultant other than by will or the laws of descent and distribution or, in the case of non-Incentive Stock Options, pursuant to a Qualified Domestic Relations Order or as otherwise permitted pursuant to Section 11.7 of the 2012 Equity Incentive Plan. During the lifetime of the Consultant, the Stock Options shall be exercisable only by such Consultant (or by such Consultant’s guardian or legal representative, should one be appointed).
6. Notice of Exercise of Option. The Stock Options may be exercised by the Consultant, or by the Consultant’s administrators, executors or personal representatives, by a written notice signed by the Consultant, or by such administrators, executors or personal representatives, and delivered or mailed to the Company to the attention of the President, Chief Executive Officer or such other officer as the President or Chief Executive Officer may designate. Any such notice shall:
(a) specify the number of shares of Common Stock which the Consultant or the Consultant’s administrators, executors or personal representatives, as the case may be, then elects to purchase hereunder,
(b) contain such information as may be reasonably required pursuant to Section 10 below, and
(c) be accompanied by (i) a certified or cashier’s check or, if acceptable to the Committee, a recourse note payable to the Company in payment of the total Exercise Price applicable to such shares as provided herein,
(ii) shares of Common Stock owned by the Consultant and duly endorsed or accompanied by stock transfer powers having a Fair Market Value equal to the total Exercise Price applicable to such shares purchased under this Agreement, (iii) shares otherwise issuable upon exercise of the Stock Options having a Fair Market Value equal to the total Exercise Price applicable to such shares purchased under this Agreement or (iv) a certified or cashier’s check or, if acceptable to the Committee, a recourse note payable to the Company, accompanied by the number of shares of Common Stock whose Fair Market Value when added to the amount of the check or note equals the total Exercise Price applicable to the shares being purchased under this Agreement.
Upon receipt of any such notice and accompanying payment, and subject to the terms hereof, the Company agrees to issue to the Consultant or the Consultant’s administrators, executors or personal representatives, as the case may be, stock certificates for the number of shares specified in such notice registered in the name of the person exercising the Stock Options.
7. Issuance of Stock Certificates for Shares. The stock certificates for any shares of Common Stock issuable to the Consultant upon exercise of the Stock Options shall be delivered to the Consultant (or to the person to whom the rights of the Consultant shall have passed by will or the laws of descent and distribution) as promptly after the date of exercise as is feasible, but not before the Consultant has paid the option price for such shares.
8. Termination of Consulting Services.
(a) Except as otherwise specified in the Notice of Grant for the Stock Options covered by this Agreement, in the event of the termination of the Consultant’s consulting services for the Company, other than a termination that is either (i) for Cause, (ii) voluntarily initiated on the part of the Consultant and without written consent of the Company, or (iii) for reasons of death or retirement, the Consultant may exercise the vested portion of the Stock Options at any time within ninety (90) days after such termination to the extent of the number of shares which were Purchasable Shares under the vesting schedule in the Notice of Grant at the date of such termination.
(b) Except as specified in the Notice of Grant for the Stock Options attached hereto, in the event of a termination of the Consultant’s consulting services that is either (i) for Cause or (ii) voluntarily initiated on the part of the Consultant and without the written consent of the Company, the Stock Options, to the extent not previously exercised, shall terminate immediately and shall not thereafter be or become exercisable.
9. Death of Consultant. Except as otherwise set forth in the Notice of Grant with respect to the rights of the Consultant upon termination of the consulting services for the Company under Section 8(a) above, in the event of the Consultant’s death while performing consulting services for the Company or within three months after termination of such consulting services (if such termination was neither (i) for cause nor (ii) voluntary on the part of the Consultant and without the written consent of the Company), the appropriate persons described in Section 6 of this Agreement or persons to whom all or a portion of the Stock Options is transferred in accordance with Section 5 of this Agreement may exercise the Stock Options at any time within a period ending on the earlier of (a) the last day of the one year period following the Consultant’s death or (b) the expiration date of the Stock Options specified in the Notice of Grant. If the Consultant was actively performing consulting services for the Company at the time of death, any unvested rights to acquire shares pursuant to the Stock Options shall immediately vest and the Stock Options may be so exercised to the extent of the number of shares that were Purchasable Shares under the vesting schedule in the Notice of Grant at the date of death. If the Consultant’s consulting services terminated prior to his or her death, the Stock Options may be exercised only to the extent of the number of shares covered by the Stock Options which were Purchasable Shares under the vesting schedule in the Notice of Grant at the date of such termination.
10. Compliance with Regulatory Matters. The Consultant acknowledges that the issuance of capital stock of the Company is subject to limitations imposed by federal and state law, and the Consultant hereby agrees that the Company shall not be obligated to issue any shares of Common Stock upon an attempted exercise of this Stock Options that would cause the Company to violate law or any rule, regulation, order or consent decree of any regulatory authority (including without limitation the SEC) having jurisdiction over the affairs of the Company. The Consultant agrees that he or she will provide the Company with such information as is reasonably requested by the Company or its counsel to determine whether the issuance of Common Stock complies with the provisions described by this Section 10.
11. Adjustment in Option. The number of Shares subject to these Stock Options, the Exercise Price and other matters are subject to adjustment during the term of the Stock Options in accordance with Section 4.3 of the 2012 Equity Incentive Plan.
12. Rights Prior to Issuance of Certificates. Neither the Consultant nor any person to whom the rights of the Consultant shall have passed by will or the laws of descent and distribution shall have any of the rights of a shareholder with respect to any shares of Common Stock until the date of the issuance to him of certificates for such Common Stock as provided in Section 7 above.
13. Miscellaneous.
(a) This Agreement shall be binding upon the parties hereto and their representatives, successors and assigns.
(b) This Agreement shall be governed by the laws of, the State of Florida.
(c) Any requests or notices to be given hereunder shall be deemed given, and any elections or exercises to be made or accomplished shall be deemed made or accomplished, upon actual delivery thereof to the designated recipient, or three days after deposit thereof in the United States mail, registered, return receipt requested and postage prepaid, addressed, if to the Consultant, at the most recent mailing address provided to the Company in writing, and, if to the Company, to the executive offices of the Company at, 4902 Eisenhower Blvd., Suite 125, Tampa, Florida 33634 or at such other addresses that the parties provide to each other in accordance with the foregoing notice requirements.
(d) This Agreement may not be modified except in writing executed by each of the parties to it.
(e) This Agreement is subject to all terms and provisions of the Plan. In the event of a conflict between one or more provisions of this Agreement and one or more provisions of the Plan, the provisions of the Plan will govern.
(f) Neither this Agreement nor the Stock Options confer upon the Consultant any right with respect to continuance of consulting services for the Company.
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 3/31/13 | 10-Q | |||
| Filed on: | 3/26/13 | |||
| For Period end: | 12/31/12 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/29/24 Oragenics Inc. 10-K 12/31/23 80:6.5M M2 Compliance LLC/FA 4/17/23 Oragenics Inc. 10-K 12/31/22 75:6.9M M2 Compliance LLC/FA 7/29/22 Oragenics Inc. 10-K/A 12/31/21 72:6.4M M2 Compliance LLC/FA 3/24/22 Oragenics Inc. 10-K 12/31/21 77:7M M2 Compliance LLC/FA 3/01/21 Oragenics Inc. 10-K 12/31/20 79:6M M2 Compliance LLC/FA |